drugset / Trial / NCT04071262
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see if the study drug abemaciclib in combination with other anti-cancer therapies is safe in Japanese participants with advanced cancer.
Timeline
- Start
- 2019-12-20
- Primary completion
- 2021-02-12
- Completion
- 2021-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abemaciclib | Small molecule | — | Oral |
| Background | Abiraterone acetate | Small molecule | — | Oral |
| Background | Prednisolone | Other / unclassified | — | Oral |